Michael Thomas Heffernan - 17 Jun 2025 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role: Director
Signature: /s/ Donald R. Reynolds, by Power of Attorney
Issuer symbol: AVTX
Transactions as of: 17 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 18 Jun 2025, 16:19:55 UTC
Previous filing: 13 Jun 2025
Next filing: 08 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Heffernan Michael Thomas	Director	C/O AVALO THERAPEUTICS, INC., 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE	/s/ Donald R. Reynolds, by Power of Attorney	18 Jun 2025	0001448914

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVTX	Stock Option (Right to Buy)	Award	$0	+29,500		$0.000000	29,500	17 Jun 2025	Common Stock	29,500	$4.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date.